Christine Mikail Cvijic - Mar 13, 2024 Form 4 Insider Report for Neurogene Inc. (NGNE)

Role
President and CFO
Signature
/s/ Christine Mikail
Stock symbol
NGNE
Transactions as of
Mar 13, 2024
Transactions value $
$0
Form type
4
Date filed
3/14/2024, 08:53 PM
Previous filing
Dec 26, 2023
Next filing
Nov 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGNE Common Stock Award $0 +31.9K +152.35% $0.00 52.8K Mar 13, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGNE Employee Stock Option (Right to buy) Award $0 +53.9K $0.00 53.9K Mar 13, 2024 Common Stock 53.9K $36.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/4 of the total number of shares on March 13, 2025, and then 1/48 of the total number of shares will vest monthly thereafter, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.